HTA211 Are Surrogate Endpoints a Way Forward in Non-Small Cell Lung Cancer (NSCLC)? A Comparison of HTA Outcomes Across Germany, France, and the UK
Abstract
Authors
Y Ergin S Kassenaar P Macnair K Malliou-Najjar
Y Ergin S Kassenaar P Macnair K Malliou-Najjar
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now